Influence of pretreatment polarographically measured oxygenation levels in spontaneous canine tumors treated with radiation therapy

Strahlentherapie und Onkologie

Volumn 182, Issue 9, 2006, Pages 518-524

  Bley, Carla Rohrer ^a   Ohlerth, Stefanie ^a   Roos, Malgorzata ^a   Wergin, Melanie ^a   Achermann, Roger ^a   Kaser Hotz, Barbara ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Canine tumors; Hypoxia; Polarographic needle electrode; Radiation therapy; Tumor oxygenation

Indexed keywords

HEMOGLOBIN;

ACANTHOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; FIBROSARCOMA; HEMANGIOPERICYTOMA; HEMOGLOBIN BLOOD LEVEL; HISTIOCYTOMA; HISTOPATHOLOGY; LIPOMA; MALE; MELANOMA; MYXOSARCOMA; NONHUMAN; OSTEOSARCOMA; OVERALL SURVIVAL; POLAROGRAPHY; PROGNOSIS; SPINDLE CELL SARCOMA; SQUAMOUS CELL CARCINOMA; TISSUE OXYGENATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR;

AGE FACTORS; ANIMALS; CELL HYPOXIA; DATA INTERPRETATION, STATISTICAL; DOG DISEASES; DOGS; ELECTRODES; FEMALE; FOLLOW-UP STUDIES; MALE; NEOPLASMS; OXYGEN; PALLIATIVE CARE; POLAROGRAPHY; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 33748136112     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1519-7     Document Type: Article

References (40)

1. Achermann R, Ohlerth S, Fidel J, et al. Ultrasound-guided, pre-radiation oxygen measurements using polarographic oxygen needle electrodes in spontaneous canine soft tissue sarcomas. In Vivo 2002;16:431-7.
2. Achermann RE, Ohlerth SM, Rohrer Bley C, et al. Oxygenation of spontaneous canine tumors during fractionated radiation therapy. Strahlenther Onkol 2004;180:297-305.
3. Brizel DM, Dodge RK, Clough RW, et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-7.
4. Brizel DM, Rosner GL, Harrelson J, et al. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1994;30:635-42.
5. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-3.
6. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285-9.
7. Bruehlmeier M, Achermann R, Kaser-Hotz B, et al. Measurement of tumor hypoxia and perfusion in spontaneous canine tumors using positron emission tomography with [18F]-fluoromisonidazole, [18F]-EF5 and [150]-H2O. Vet Radiol Ultrasound 2006;46:348-54.
8. Brurberg KG, Skogmo HK, Graff BA, et al. Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol 2005;77:220-6.
9. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214-21.
10. Clarke H, Pallister CJ. The impact of anaemia on outcome in cancer. Clin Lab Haematol 2005;27:1-13.
11. Cline JM, Thrall DE, Rosner GL, et al. Distribution of the hypoxia marker CCI-103F in canine tumors. Int J Radiat Oncol Biol Phys 1994;28:921-33.
12. Dunst J. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing? Strahlenther Onkol 2004;180:671-81.
13. Dunst J, Kuhnt T, Strauss HG, et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-87.
14. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003;195:1-16.
15. 18F]-2-fluoro-2′-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 2004;180:616-22.
16. Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 2004;9:Suppl 5:31-40.
17. Harrison LB, Chadha M, Hill RJ, et al. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002;7:492-508.
18. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
19. Höckel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
20. 2 tension measurements. Cancer Res 1991;51:6098-102.
21. Kelleher DK, Matthiensen U, Thews O, et al. Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol 1995;34:379-84.
22. Lartigau E, Le Ridant AM, Lambin P, et al. Oxygenation of head and neck tumors. Cancer 1993;71:2319-25.
23. Lartigau E, Randrianarivelo H, Avril MF, et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 1997;7:400-6.
24. Movsas B, Chapman JD, Greenberg RE, et al. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. Cancer 2000;89:2018-24.
25. Nordsmark M, Bentzen SM, Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol 1994;33:383-9.
26. Nordsmark M, Hoyer M, Keller J, et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1996;35:701-8.
27. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000;57:39-43.
28. Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 2004;43:396-403.
29. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
30. Nozue M, Lee I, Yuan F, et al. Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker. J Surg Oncol 1997;66:30-8.
31. Raleigh JA, Zeman EM, Calkins DP, et al. Distribution of hypoxia and proliferation-associated markers in spontaneous canine tumors. Acta Oncol 1995;34:345-9.
32. Rasey JS, Koh WJ, Grierson JR, et al. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 1989;17:985-91.
33. Rudat V, Vanselow B, Wollensack P, et al. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. Radiother Oncol 2000;57:31-7.
34. Stadler P, Becker A, Feldmann HJ, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:749-54.
35. Steel GG. The growth rate of tumours. In: Steel GG, ed. Basic clinical radiobiology, 3rd edn. New York: Arnold, 2002:8-22.
36. Sundfor K, Lyng H, Trope CG, et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 2000;54:101-7.
37. Van Belle SJ, Cocquyt V. Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol 2003;47:1-11.
38. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-65.
39. 2 tension measurements. Cancer Res 1991;51:3316-22.
40. Zips D, Adam M, Flentje M, et al. Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project. Strahlenther Onkol 2004;180:609-15.